86882-62-4

Upstream product

• 1424077-24-6 tert-butyl{1-[2-methoxy-4-(methoxymethoxy)phenyl]ethoxy}dimethylsilane 
• 98-88-4 benzoyl chloride 
• 1424077-28-0 [3-(1-{[tert-butyl(dimethyl)silyl]oxy}ethyl)-2-methoxy-6-(methoxymethoxy)phenyl](phenyl)methanone 
• 89-84-9 2',4'-dihydroxy-4-acetophenone 
• 70-11-1 α-bromoacetophenone 
• 1424077-17-7 1-(2-benzoyl-4-methoxy-3-phenyl-1-benzofuran-5-yl)ethanone 
• 1424077-10-0 C₂₃H₁₆O₄ 
• 1099-45-2 ethyl (triphenylphosphoranylidene)acetate 
• 90-33-5 7-hydroxy-4-methyl-chromen-2-one 
• 66185-72-6 7-(phenylcarbonyl)oxy-4-methyl-2H-1-benzopyran-2-one 
• 65490-08-6 2-hydroxy-4-(methoxymethoxy)acetophenone 
• 75227-17-7 1-(2-methoxy-4-(methoxymethoxy)phenyl)ethan-1-one 
• 68454-14-8 8-benzoyloxy-7-hydroxy-4-methylcoumarin 

Relevant academic research and scientific papers

An efficient, mild and scalable synthesis of bioactive compounds containing the angelicin scaffold

An efficient, mild and scalable synthesis of angelicin scaffold based compounds was developed. Particularly, the new synthetic route described here circumvents the need for the previously reported key Fries rearrangement step, which uses impractically har

COUMARIN COMPOUNDS AND THEIR USE FOR TREATING CANCER

Coumarin compounds of formula (I): wherein R1, R2, R3, R4, R5, R6, and X are defined herein. Also disclosed is a method for treating cancer with coumarin compounds.

COUMARIN COMPOUNDS AND THEIR USE FOR TREATING VIRAL INFECTION

A method for treating an infection with a virus. The method includes administering to a subject in need thereof an effective amount of one or more coumarin compounds of formula (I): wherein R1, R2, R3, R4, Rsub